Eaton Vance Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$49.9M Sell
687,489
-9
-0% -$670 0.07% 262
2022
Q2
$46.7M Sell
687,498
-153,518
-18% -$11M 0.07% 281
2022
Q1
$76.2M Buy
841,016
+3,526
+0.4% +$289K 0.09% 221
2021
Q4
$76.4M Buy
837,490
+133,808
+19% +$11.5M 0.09% 217
2021
Q3
$57.1M Buy
703,682
+112,524
+19% +$9.45M 0.08% 239
2021
Q2
$55.1M Buy
591,158
+159,197
+37% +$15.4M 0.07% 250
2021
Q1
$46.2M Buy
431,961
+393,134
+1,013% +$40.8M 0.07% 273
2020
Q4
$3.39M Buy
+38,827
New +$2.74M 0.01% 806
2020
Q3
Sell
-12,261
Closed -$594K 1342
2020
Q2
$594K Buy
+12,261
New +$586K ﹤0.01% 1076

Other funds holding NARI

Eaton Vance Management's NARI Position: Q3 2022 in Review

Eaton Vance Management reduced its Inari Medical, Inc. Common Stock (NARI) stake by 0% in Q3 2022, selling an estimated $670 and leaving 687,489 shares worth $49.9M. The position accounts for 0.07% of the portfolio, ranked #262.

Eaton Vance Management first reported a position in NARI in Q2 2020 and has held it in 9 quarters since. The position peaked at $76.4M in Q4 2021. 240 funds tracked by Wall St. Rank hold NARI as of Q3 2022.

  • Eaton Vance Management held 687,489 shares of Inari Medical, Inc. Common Stock worth $49.9M as of Q3 2022.
  • Eaton Vance Management sold 9 Inari Medical, Inc. Common Stock shares in Q3 2022, an estimated $670.
  • Inari Medical, Inc. Common Stock made up 0.07% of Eaton Vance Management's portfolio in Q3 2022, its #262 holding.
  • Eaton Vance Management first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and has held it in 9 quarters since.
  • Eaton Vance Management's Inari Medical, Inc. Common Stock position peaked at $76.4M in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.